[HTML][HTML] TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation

D Wieland, J Kemming, A Schuch, F Emmerich… - Nature …, 2017 - nature.com
D Wieland, J Kemming, A Schuch, F Emmerich, P Knolle, C Neumann-Haefelin, W Held
Nature communications, 2017nature.com
Differentiation and fate of virus-specific CD8+ T cells after cessation of chronic antigen
stimulation is unclear. Here we show that a TCF1+ CD127+ PD1+ hepatitis C virus (HCV)-
specific CD8+ T-cell subset exists in chronically infected patients with phenotypic features of
T-cell exhaustion and memory, both before and after treatment with direct acting antiviral
(DAA) agents. This subset is maintained during, and for a long duration after, HCV
elimination. After antigen re-challenge the less differentiated TCF1+ CD127+ PD1+ …
Abstract
Differentiation and fate of virus-specific CD8+ T cells after cessation of chronic antigen stimulation is unclear. Here we show that a TCF1+CD127+PD1+ hepatitis C virus (HCV)-specific CD8+ T-cell subset exists in chronically infected patients with phenotypic features of T-cell exhaustion and memory, both before and after treatment with direct acting antiviral (DAA) agents. This subset is maintained during, and for a long duration after, HCV elimination. After antigen re-challenge the less differentiated TCF1+CD127+PD1+ population expands, which is accompanied by emergence of terminally exhausted TCF1-CD127-PD1hi HCV-specific CD8+ T cells. These results suggest the TCF1+CD127+PD1+ HCV-specific CD8+ T-cell subset has memory-like characteristics, including antigen-independent survival and recall proliferation. We thus provide evidence for the establishment of memory-like virus-specific CD8+ T cells in a clinically relevant setting of chronic viral infection and we uncover their fate after cessation of chronic antigen stimulation, implicating a potential strategy for antiviral immunotherapy.
nature.com